Sage Journals: Discover world-class research

Abstract

Background:

Cardiopulmonary bypass (CPB) during open-heart surgery triggers an inflammatory response that can cause significant morbidity and mortality. Human monocytes and regulatory T (Treg) cells are phenotypically and functionally heterogeneous and have been shown to play a significant role in the inflammatory dysfunction triggered by CPB. Glucocorticoids (GCs) have been widely administered for decades in patients undergoing CPB to reduce this inflammatory response. However, it has not been clearly established how routine prophylactic administration of glucocorticoids (GCs) affects monocyte and Treg subsets.

Methods:

Thirty-six patient who underwent heart surgery with CPB were randomly assigned to a methylprednisolone group (MG, N = 18; 500 mg in the CPB priming) and a non-methylprednisolone group (NMG, N = 18). The circulating monocyte and Treg subsets were analyzed by flow cytometry.

Results:

The MG and NMG groups had comparable percentages of monocyte subsets and similar expression levels of HLA-DR, CD86, CD64 and toll-like receptor 4 (TLR4). Remarkably, methylprednisolone increased the percentage of CD4+CD25+ Treg cells among CD4+ T cells in patients undergoing CPB, but did not increase the proportion of suppressive Treg cells, either resting or activated, in these patients undergoing CPB.

Conclusions:

Our results showed that prophylactic administration of methylprednisolone neither decreased the percentages and counts of inflammatory monocyte subsets nor did it induce the expansion of suppressive Treg cells in patients undergoing CPB. These results clarified the effects of GCs on cell-mediated immune responses and provided additional evidence in practice.

Trial registration:

Clinicaltrials.gov: NCT01296074. Registered 14 February 2011.

Keywords

cardiopulmonary bypass (CPB)inflammatory response monocyte subsets regulatory T cell (Treg) subpopulations methylprednisolone

Get full access to this article

View all access options for this article.

References

Edmunds

LH.

Cardiopulmonary bypass after 50 years. N Engl J Med 2004; 351: 1603–1606.

Conti

VR.

Pulmonary injury after cardiopulmonary bypass. Chest 2001; 119: 2–4.

Bocsi

Hanzka

Osmancik

et al . Modulation of the cellular and humoral immune response to pediatric open-heart surgery by methylprednisolone. Cytometry B Clin Cytom 2011; 80: 212–220.

Morariu

Loef

Aarts

et al . Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005; 128: 2677–2687.

Heying

Wehage

Schumacher

et al . Dexamethasone pretreatment provides antiinflammatory and myocardial protection in neonatal arterial switch operation. Ann Thorac Surg 2012; 93: 869–876.

Guilpain

Le Jeunne

Anti-inflammatory and immunosuppressive properties of corticosteroids. Presse Med 2012; 41: 378–383.

Whitlock

Devereaux

Teoh

et al . Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet 2015; 386: 1243–1253.

Shi

Pamer

EG.

Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11: 762–774.

Miyara

Yoshioka

Kitoh

et al . Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899–911.

10.

Ehrchen

Steinmuller

Barczyk

et al . Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 2007; 109: 1265–1274.

11.

Cain

Cidlowski

JA.

Immune regulation by glucocorticoids. Nat Rev Immunol 2017; 17: 233–247.

12.

Fattorossi

Battaglia

Buzzonetti

et al . Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 2005; 116: 134–141.

13.

Chen

Oppenheim

Winkler-Pickett

et al . Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol 2006; 36: 2139–2149.

14.

Olsen

Kitoko

Ferreira

et al . Glucocorticoids decrease Treg cell numbers in lungs of allergic mice. Eur J Pharmacol 2015; 747: 52–58.

15.

Liu

Dhanda

Hirani

et al . CD14++CD16+ Monocytes are enriched by glucocorticoid treatment and are functionally attenuated in driving effector T cell responses. J Immunol 2015; 194: 5150–5160.

16.

Gordon

Taylor

PR.

Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953–964.

17.

Xing

Han

Hao

et al . Immature monocytes contribute to cardiopulmonary bypass-induced acute lung injury by generating inflammatory descendants. Thorax 2017; 72: 245–255.

18.

Hou

Sun

Hao

et al . Imbalance between subpopulations of regulatory T cells in COPD. Thorax 2013; 68: 1131–1139.

19.

Hao

Han

Xing

et al . Urinary trypsin inhibitor attenuated inflammatory response of patients undergoing cardiopulmonary bypass by inducing activated Treg cells. Inflammation 2013; 36: 1279–1285.

20.

Tan

JA.

Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation 2009; 119: 1853–1866.

21.

Graham

Atz

Butts

et al . Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery: results from a randomized trial. J Thorac Cardiovasc Surg 2011; 142: 1523–1529.

22.

Dieleman

Nierich

Rosseel

et al . Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 2012; 308: 1761–1767.

23.

Kok

Hillegers

Veldhuijzen

et al . The effect of dexamethasone on symptoms of posttraumatic stress disorder and depression after cardiac surgery and intensive care admission: longitudinal follow-up of a randomized controlled trial. Crit Care Med 2016; 44: 512–520.

24.

Dieleman

van Paassen

van Dijk

et al . Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev 2011: D5566.

25.

Bocsi

Hanzka

Osmancik

et al . Modulation of the cellular and humoral immune response to pediatric open-heart surgery by methylprednisolone. Cytometry B Clin Cytom 2011; 80: 212–220.

26.

Zeng

Dong

Ruan

et al . CD14+CD16++ monocytes are increased in patients with NMO and are selectively suppressed by glucocorticoids therapy. J Neuroimmunol 2016; 300: 1–8.

27.

Venet

Tissot

Debard

et al . Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock. Crit Care Med 2007; 35: 1910–1917.

28.

Sojka

Huang

Fowell

DJ.

Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology 2008; 124: 13–22.

29.

Sbiera

Dexneit

Reichardt

et al . Influence of short-term glucocorticoid therapy on regulatory T cells in vivo. PLoS One 2011; 6: e24345.

30.

Lim

Muller

Herold

et al . Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 2007; 122: 47–53.

31.

Munck

Naray-Fejes-Toth

The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited. Mol Cell Endocrinol 1992; 90: C1–C4.

32.

Sapolsky

Romero

Munck

AU.

How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000; 21: 55–89.

33.

Dhabhar

McEwen

BS.

Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 1999; 96: 1059–1064.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.24 MB

The effect of methylprednisolone prophylaxis on inflammatory monocyte subsets and suppressive regulatory T cells of patients undergoing cardiopulmonary bypass